Thus, GEM, S100B, and GZMA might be involved in the muscle dysfunction for COPD patients by ALS-related signaling pathways and might participate in the inflammatory response in COPD by regulating macrophage polarization, and these genes might act as the potential therapeutic targets for muscle atrophy of COPD patients. Here, GEM is linked to amyotrophic lateral sclerosis.